OneSource and Orbicular secure USFDA tentative approval for generic semaglutide injection
Partnership progresses ANDA filing for generic version of Ozempic with manufacturing support from OneSource
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India’s biopharma moment—If we get the ecosystem right
Krishna Sarma highlights the ecosystem requirements for advancing biopharma innovation in India
Morepen Laboratories clears fourth USFDA inspection at Masulkhana facility with NIL 483
Outcome follows Rs 825 crore CDMO mandate and supports global manufacturing engagements
Clinical exclusivity for indigenous medicines can improve long-term affordability and access
Nikkhil Masurkar, CEO, Entod Pharmaceuticals opines that in the absence of clinical data exclusivity, competitors may obtain…
Rusan Pharma secures PMDA GMP approval for Ankleshwar and Dehradun facilities
Approval from Japan regulator covers API and finished dosage manufacturing units
Lupin subsidiary enters settlement agreement with Humana in US antitrust litigation
Lupin Pharmaceuticals Inc to pay USD 30 million under agreement without admission of liability
Aurobindo Pharma secures USFDA approval for Glycerol Phenylbutyrate Oral Liquid
Company to launch product for urea cycle disorders with market size of US$ 50.2 million
Alembic Pharma gets USFDA nod for Methotrexate Injection USP, 50 mg/2 mL multi-dose vials and 1g/40…
Methotrexate Injection is a folate analog metabolic inhibitor indicated for neoplastic diseases
Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical…
The shift reflects intensifying demand for metabolic therapies and growing logistics risk, signaling a structural move toward…
Rubicon Research acquires 85% stake in Arinna Lifesciences
Transaction valued at INR 200 crore to expand presence in CNS therapies and domestic formulations market